A French CDK4-positive melanoma family with a co-inherited EDNRB mutation

Journal of Dermatological Science

Volumn 46, Issue 1, 2007, Pages 61-64

  Soufir, Nadem ^a   Ollivaud, Laurence ^b   Bertrand, Guylene ^a   Lacapère, Jean Jacques ^a   Descamps, Vincent ^a   Vitoux, Dominique ^b   Lebbe, Céleste ^b   Wolkenstein, Pierre ^c   Dupin, Nicolas ^d   Saiag, Philippe ^e   Basset Seguin, Nicole ^b   Grandchamp, Bernard ^a  

^a BICHAT HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d NONE   (France)

^e HÔPITAL AMBROISE PARÉ   (France)

Author keywords

CDK4; EDNRB; Melanoma genetics

Indexed keywords

CYCLIN DEPENDENT KINASE 4; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR B; GENOMIC DNA; UNCLASSIFIED DRUG;

CELL CYCLE ARREST; CLINICAL ASSESSMENT; CUTANEOUS MELANOMA; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC TRAIT; HIRSCHSPRUNG DISEASE; LETTER; MELANOMA; MUTATIONAL ANALYSIS; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL;

EID: 33847768225     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2006.11.016     Document Type: Letter

References (10)

1. Holland E.A., Schmid H., Kefford R.F., and Mann G.J. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 25 (1999) 339-348
2. Zuo L., Weger J., Yang Q., Goldstein A.M., Tucker M.A., Walker G.J., et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12 (1996) 97-99
3. Winsey S.L., Haldar N.A., Marsh H.P., Bunce M., Marshall S.E., Harris A.L., et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60 (2000) 5612-5616
4. Matichard E., Verpillat P., Meziani R., Gerard B., Descamps V., Legroux E., et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41 (2004) e13
5. Soufir N., Meziani R., Lacapere J.J., Bertrand G., Fumeron F., Bourillon A., et al. Association between endothelin receptor B nonsynonymous variants and melanoma risk. J Natl Cancer Inst 97 (2005) 1297-1301
6. Molven A., Grimstvedt M.B., Steine S.J., Harland M., Avril M.F., Hayward N.K., et al. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer 44 1 (2005) 10-18
7. Amiel J., Attie T., Jan D., Pelet A., Edery P., Bidaud C., et al. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum Mol Genet 5 (1996) 355-357
8. Fuchs S., Amiel J., Claudel S., Lyonnet S., Corvol P., and Pinet F. Functional characterization of three mutations of the endothelin B receptor gene in patients with Hirschsprung's disease: evidence for selective loss of Gi coupling. Mol Med 7 (2001) 115-124
9. McCallion A.S., Stames E., Conlon R.A., and Chakravarti A. Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb. Proc Natl Acad Sci USA 100 (2003) 1826-1831
10. Loercher A.E., Tank E.M., Delston R.B., and Harbour J.W. MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol 168 (2005) 35-40